CD BioGlyco offers a premier nutritional control optimization service designed to bridge the gap between metabolic potential and high-titer production. We recognize that glycoconjugates and complex carbohydrates are metabolically expensive for a chassis to produce. Therefore, the strategic delivery of carbon sources, nitrogen precursors, and trace micronutrients is not merely a logistical necessity but a critical determinant of product quality and structural integrity. Our service focuses on the fine-tuned synchronization of nutrient availability with the physiological demands of the host cell, ensuring maximum flux toward the desired glycan pathways while minimizing inhibitory byproduct formation.
Key Technologies
Dynamic Feed-on-Demand (DFD) Systems
We utilize advanced sensors to monitor real-time metabolic markers such as dissolved oxygen (DO), pH, and carbon dioxide evolution rate (CER). By integrating these signals with automated algorithmic controllers, we maintain nutrient concentrations at growth-limiting yet production-optimal levels, preventing the Crabtree effect and acetate accumulation.
Stoichiometric Metabolic Flux Analysis (sMFA)
Our specialists use computational models to map the flow of atoms through the metabolic network of the chassis. By understanding the specific stoichiometric requirements for glycan polymerization, including the energetic cost of nucleotide sugar donor synthesis, we tailor the nutrient media to provide the exact precursors needed for decoration and chain elongation.
Chemically Defined Media (CDM) Customization
Moving away from complex, variable components like yeast extract, we develop high-performance CDM. This technology allows for absolute control over every molecular input, ensuring batch-to-batch consistency and simplifying downstream purification processes for therapeutic-grade glycobiologicals.
Orchestrating Metabolic Harmony through Nutrient Precision
At CD BioGlyco, our nutritional control optimization service is a specialized vertical within our broader synthetic biology-based fermentation service and fermentation process optimization service. We understand that the "chassis", whether it be Escherichia coli, Pichia pastoris, or mammalian cells, is a living factory whose efficiency is dictated by its diet. Our scope of service encompasses the entire lifecycle of nutritional management, from initial media screening to the implementation of sophisticated fed-batch and continuous feeding profiles.
The primary focus of this service is the mitigation of metabolic stress. When a chassis is engineered to produce complex glycans, such as human milk oligosaccharides (HMOs) or glycosylated proteins, the demand for specific precursors like UDP-GlcNAc or GDP-fucose skyrockets. If the nutritional environment is not optimized, the cell may prioritize survival over synthesis, leading to incomplete glycosylation patterns or low titers. We provide a detailed analysis of your specific strain's nutrient consumption rates and metabolic bottlenecks.
Our methodology involves the systematic evaluation of carbon-to-nitrogen (C/N) ratios, the supplementation of specific amino acids that act as amino-group donors for hexosamines, and the titration of metal ions (e.g., Mn2+, Mg2+), which serve as essential cofactors for glycosyltransferases. We implement advanced design of experiments (DoE) approaches, such as Plackett-Burman and response surface methodology (RSM), to identify synergistic effects between different nutritional components. By the conclusion of our service, clients receive a validated feeding strategy that maximizes biomass density, enhances product potency, and ensures that the glycan profile meets strict specifications.
Workflow
Metabolic Baseline Characterization
We begin by analyzing the current performance of your chassis under standard conditions. This includes quantifying nutrient uptake rates and identifying the onset of metabolic shifts or inhibitory byproduct formation.
Media Component Screening
Using high-throughput micro-bioreactors, we screen hundreds of nutrient combinations. This step identifies the "essential few" components that impact glycan titer and quality, moving beyond generic formulations.
Statistical Media Optimization
We apply RSM to determine the optimal concentrations of identified key components. This creates a mathematical model of the nutritional space, allowing us to predict performance under various supply scenarios.
Feeding Strategy Development
Based on the growth kinetics of the strain, we design bespoke feeding profiles, such as exponential, constant, or pH-stat feeding, to maintain the cell in a high-productivity state for the duration of the fermentation.
Scale-Up Validation and Pilot Testing
The optimized nutritional strategy is validated in benchtop bioreactors (5L to 50L). We ensure that the nutritional control established at the micro-scale translates to larger volumes, accounting for mass transfer limitations.
A Technical Reporting
Clients receive a detailed dossier containing all experimental data, optimized media recipes, and operational parameters for the feeding controllers, ensuring a seamless transition to their own facilities.
Publication Data
DoI: 10.1186/s12934-025-02652-w
Journal: Microbial Cell Factories
IF: 4.9
Published: 2025
Results: This study optimized fermentation conditions for Streptomyces sp. KN37 to boost antifungal metabolite production against crop pathogens like Rhizoctonia solani. Using single-factor tests, Plackett–Burman design, and response surface methodology, researchers identified millet, yeast extract, and K2HPO4 as key medium components. The optimized conditions were 20 g/L millet, 1 g/L yeast extract, 0.5 g/L K2HPO4, 150 r/min, 25 °C, initial pH 8, 9 days, 4% inoculum, and 100 mL liquid volume. The antifungal inhibition rate rose from 27.33% to 59.53%. Metabolomic and transcriptomic analyses revealed large increases in 4‑(diethylamino) salicylaldehyde and N‑(2,4‑dimethylphenyl) formamide, linked to downregulated salicylaldehyde dehydrogenase. These results support agricultural biocontrol applications.
Fig.1 Optimization of fermentation conditions to increase the production of antifungal metabolites from Streptomyces sp. KN37. (Yang, et al., 2025)
Applications
Therapeutic Glycoprotein Production
Ensuring consistent N-glycosylation and O-glycosylation profiles in monoclonal antibodies (mAbs) by controlling the availability of nucleotide sugar donors through precise nitrogen and trace element management.
HMO Biosynthesis
Optimizing the production of complex HMO in microbial hosts by balancing lactose feeding with the metabolic load of the pentose phosphate pathway.
Vaccine Adjuvant Synthesis
Maximizing the yield of glycoconjugates used in modern vaccine formulations by stabilizing the metabolic flux toward lipid A or other polysaccharide backbones.
Functional Ingredients
Enhancing the titer of bioactive rare sugars and prebiotic fibers through cost-effective, high-density fermentation strategies that utilize sustainable carbon sources.
Advantages
Unmatched Expertise
Our team comprises specialists who understand the unique metabolic "toll" of glycan synthesis, allowing us to design strategies that others might overlook.
State-of-the-Art Instrumentation
We utilize parallel bioreactor systems and real-time analytical tools to capture high-resolution data on nutrient dynamics and cellular response.
Customized Solutions
We do not believe in a "one size fits all" media; every strategy is tailored to the specific genetic makeup of your engineered chassis.
Accelerated Timelines
By leveraging high-throughput screening and advanced statistical modeling, we significantly reduce the time required to reach an optimized production state.
Frequently Asked Questions
Customer Review
"The team at CD BioGlyco transformed our HMO production process. Their NCOS approach reduced our primary byproduct by 60%, allowing us to achieve titers we previously thought were impossible in a 50L scale."
– Y.S., Principal Scientist, Global Nutrition Corp.
"Working with CD BioGlyco provided us with a chemically defined medium that finally gave us the batch-to-batch consistency. Their expertise in glycan-specific nutrient requirements is unparalleled."
"Exceptional technical support and data-driven results. The feeding strategy developed for our glycosylated vaccine candidate significantly shortened our development timeline."
– B.S., Director of Bioprocessing, Emerging Biotech Ltd.
At CD BioGlyco, we believe that the secret to high-performance glycobiological production lies in the precision of the nutritional environment. Our nutritional control optimization service provides the technical expertise and technological infrastructure needed to turn metabolic potential into an industrial reality. By optimizing every nutrient input, we empower our clients to produce superior glycans with higher titers and unwavering consistency. Please feel free to contact us for more information and to discuss your project.
Reference
Yang, X.;et al. Optimization of fermentation conditions to increase the production of antifungal metabolites from Streptomyces sp. KN37. Microbial Cell Factories. 2025, 24: 26. (Open Access)
For research use only. Not intended for any clinical use.
Fig.1 Optimization of fermentation conditions to increase the production of antifungal metabolites from Streptomyces sp. KN37. (Yang, et al., 2025)
